跳至主要内容
临床试验/JPRN-UMIN000044754
JPRN-UMIN000044754尚未招募1 期

Phase I clinical trial to examine the safety of stereotactic radiotherapy including subclinical regions for pancreatic cancer - Clinical trial of stereotactic radiotherapy including subclinical regions for pancreatic cancer

Tohoku University0 个研究点目标入组 18 人开始时间: 2021年7月7日最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
入组人数
18

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1) A metallic stent has been inserted in the bile duct and duodenum. (2) Peritoneal dissemination has been confirmed by peritoneal cytology within 4 weeks prior to enrollment. (3) Cases with severe complication such as heart disease, renal disease, and hepatic disease (4) Fever over 38 degrees Celsius (5) Other active malignancy at the start of our study (6) Patients requiring systemic steroids medication or other immunosuppressants (7) Patients who can' t receive neither iodic drug nor gadolinium because of drug allergy (8) Cases with severe psychological disorder (9) Other cases that were judged to be inappropriate for conducting this study

研究者

相似试验